Bibliography

Found 365 results

Filters: Keyword is Internal [Clear All Filters]

2013

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.

Singer EJ, Valdes-Sueiras M, Commins D, Yong WH, Carlson M. HIV Stroke Risk: Evidence and Implications. Therapeutic Advances in Chronic Disease [Internet]. 2013 ;4(2):61-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23556125

Jacobs MM, Murray J, Byrd D, Hurd YL, Morgello S. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1and DRD2 polymorphisms in substance-dependent and substance-independent populations. Journal of NeuroVirology [Internet]. 2013 ;19(5):495-504. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24078558

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.

Byrd D, Robinson-Papp JS, Rivera-Mindt M, Mintz L, Elliott K, Lighty Q, Morgello S. Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. Journal of the International Neuropsychological Society (JINS) [Internet]. 2013 ;19(4):463-473. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23446056

Fellows RP, Byrd D, Morgello S, Bank MHIVB. Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women. Journal of the International Neuropsychological Society (JINS) [Internet]. 2013 ;19(2):216-225. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23290446

Williams DW, Calderon TM, Lopez L, Carvallo-Torres L, Gaskill PJ, Eugenin EA, Morgello S, Berman JW. Mechanisms of HIV Entry Into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis. PLoS ONE [Internet]. 2013 ;8(7). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23922698

Hall PA. Neurocognition and Medication Adherence in HIV-Infected Adults. In: Panos SE, Patel SM, Thames AD, Hinkin CH Social Neuroscience and Health. 2013th ed. Social Neuroscience and Health. Springer Publications; 2013. pp. 85-108.

Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford DB, Gelman B, McArthur JC, McCutchan JA, Simpson DM, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013 ;24(5):351-5.

Gelman B, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim C, Fox HS, Kolson DL, Grant I, Singer EJ, et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. Journal of Acquired Immune Deficiency Syndrome [Internet]. 2013 ;62(5):487-495. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23242157

Megra B, Eugenin EA, Roberts TK, Morgello S, Berman JW. Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1159-1166. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23616272

2012

Robinson-Papp JS, Elliott K, Pizzirusso M, Morgello S. Autonomic neuropathy in HIV: A case report and review of potential symptoms in an advanced-stage, HIV cohort. World Journal of AIDS [Internet]. 2012 ;2:265-269. Available from: http://www.scirp.org/journal/PaperInformation.aspx?paperID=22612

Soontornniyomkij V, Moore D, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, et al. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS [Internet]. 2012 ;26(18):2327-2335. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23018443

Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012 ;26(6):894-908.

Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012 ;18(1):79-88.

Levine AJ, Sinsheimer JS, Bilder R, Shapshak P, Singer EJ. Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults. Journal of Clinical and Experimental Neuropsychology [Internet]. 2012 ;34:78-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22082040

Choi JYong, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, et al. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 ;18(2):81-90.

Levine AJ, Service S, Miller EN, Reynolds SM, Singer EJ, Shapshak P, Martin EM, Sacktor N, Becker JT, Jacobson LP, et al. Genome-wide Association Study of Neurocognitive Impairment and Dementia in HIV-Infected Adults. Am J Med Genet B Neuropsychiatr Genet [Internet]. 2012 ;159B:669-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=22628157

Keltner JR, Vaida F, Ellis RJ, Moeller-Bertram T, Fitzsimmons C, Duarte NA, Robinson-Papp J, Dworkin RH, Clifford DB, McArthur JC, et al. Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics. 2012 ;53(4):380-6.

Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, et al. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 ;433(2):498-505.

Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, J McCutchan A, et al. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 ;59(4):376-81.

Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JAllen, et al. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.

Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, et al. Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol. 2012 ;18(6):511-20.

Gelman B, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins D, Brandt D, Grant I, et al. The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment. PLoS One [Internet]. 2012 ;7(9). Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0046178

Pages